DEFINE PCI Trial 1 Year Outcomes

Madeleine Barker presented the DEFINE PCI Trial 1 Year Outcomes. The DEFINE PCI trial (Physiologic Assessment of Coronary Stenosis Following PCI) was a multicenter, prospective, observational study in which a blinded iFR pull back was performed after angiographically successful PCI looking at a primary endpoint of the rate of residual ischemia after operator-assessed angiographically successful PCI, defined as an iFR <0.90. This paper looks at the 1 year outcomes from the trial with the endpoints of adverse clinical events (MI, target vessel revascularization or cardiovascular death) and analysis of a SAQ-AF scale. The paper was published in JACC Cardiovascular Interventions on January 10, 2022.